Cabazitaxel Accord - direct healthcare professional communication (DHPC)

cabazitaxel
DHPCHuman

Greek is available via eTranslation, the European Commission's machine translation service.

Translate to Greek | Important information about machine translation

Περί

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Έγγραφα

Direct healthcare professional communication (DHPC): Cabazitaxel Accord 20 mg/mL concentrate for solution for infusion: Risk of medication errors and mix-up with Jevtana (60 mg/1.5 mL) concentrate and solvent for solution for infusion

English (EN) (175.69 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά:
Προβολή

Key facts

Medicine name
Cabazitaxel Accord
Active substance
cabazitaxel
Therapeutic area (MeSH)
Prostatic Neoplasms, Castration-Resistant
Procedure number
EMEA/H/C/005178
DHPC type
Medication error
Human ATC codes
L01CD

Share this page